tiprankstipranks
Eisai Co Ltd (JP:4523)
TSE/TYO:4523

Eisai Co (4523) Stock Price & Analysis

0 Followers

4523 Stock Chart & Stats

Day’s Range¥0 - ¥0
52-Week Range¥5,795.00 - ¥9,796.31
Previous Close¥6,626
Volume1.46M
Average Volume (3M)1.28M
Market Cap
¥1.90T
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)44.8
Beta0.11
Nov 06, 2024
Dividend Yield2.64%
Share Statistics
EPS (TTM)147.82
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume1,278,983
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
¥7,962.51
Price Target Upside20.17% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2

Options Prices

Currently, No data available
---

Ownership Overview

0.00%9.21%7.35%83.44%
0.00%
Insiders
7.35% Other Institutional Investors
83.44% Public Companies and
Individual Investors

4523 FAQ

What was Eisai Co Ltd’s price range in the past 12 months?
Eisai Co Ltd lowest stock price was ¥5795.00 and its highest was ¥9796.31 in the past 12 months.
    What is Eisai Co Ltd’s market cap?
    Currently, no data Available
    When is Eisai Co Ltd’s upcoming earnings report date?
    Eisai Co Ltd’s upcoming earnings report date is Nov 06, 2024 which is in 125 days.
      How were Eisai Co Ltd’s earnings last quarter?
      Eisai Co Ltd released its earnings results on May 15, 2024. The company reported ¥46.395 earnings per share for the quarter, beating the consensus estimate of ¥41.074 by ¥5.321.
        Is Eisai Co Ltd overvalued?
        According to Wall Street analysts Eisai Co Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Eisai Co Ltd pay dividends?
          Eisai Co Ltd pays a Semiannually dividend of ¥85.35 which represents an annual dividend yield of 2.64%. See more information on Eisai Co Ltd dividends here
            What is Eisai Co Ltd’s EPS estimate?
            Eisai Co Ltd’s EPS estimate is ¥25.5.
              How many shares outstanding does Eisai Co Ltd have?
              Eisai Co Ltd has 296,566,960 shares outstanding.
                What happened to Eisai Co Ltd’s price movement after its last earnings report?
                Eisai Co Ltd reported an EPS of ¥46.395 in its last earnings report, beating expectations of ¥41.074. Following the earnings report the stock price went up 0.248%.
                  Which hedge fund is a major shareholder of Eisai Co Ltd?
                  Among the largest hedge funds holding Eisai Co Ltd’s share is Gilder Gagnon Howe & Co LLC.. It holds Eisai Co Ltd’s shares valued at N/A.
                    ---

                    Eisai Co Stock Smart Score

                    10
                    Unlock Smart Score
                    1
                    2
                    3
                    4
                    5
                    6
                    7
                    8
                    9
                    10

                    Company Description

                    Eisai Co Ltd

                    Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.
                    ---

                    4523 Company Deck

                    ---

                    4523 Earnings Call

                    Q4 2024
                    0:00 / 0:00
                    ---

                    4523 Stock 12 Month Forecast

                    Average Price Target

                    ¥7,962.51
                    ▲(20.17% Upside)
                    {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6078":"¥6,078","9617":"¥9,617","6962.75":"¥6,962.8","7847.5":"¥7,847.5","8732.25":"¥8,732.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":9616.057894140671,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">¥10K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7962.50945148,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">¥8K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6310.537993029816,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">¥6K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6078,6962.75,7847.5,8732.25,9617],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2023","6":"Jan<br/>2024","9":"Apr<br/>2024","12":"Jun<br/>2024","25":"Jun<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6768,6987.081376472359,7206.162752944719,7425.244129417078,7644.325505889437,7863.406882361796,8082.488258834156,8301.569635306516,8520.651011778875,8739.732388251234,8958.813764723593,9177.895141195953,9396.976517668312,{"y":9616.057894140671,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6768,6859.885342421539,6951.770684843077,7043.656027264616,7135.541369686154,7227.426712107693,7319.312054529231,7411.197396950769,7503.0827393723075,7594.968081793846,7686.853424215385,7778.738766636923,7870.624109058462,{"y":7962.50945148,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6768,6732.810614848448,6697.621229696895,6662.431844545342,6627.242459393789,6592.053074242237,6556.863689090685,6521.674303939131,6486.484918787579,6451.295533636026,6416.106148484474,6380.916763332921,6345.727378181368,{"y":6310.537993029816,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":9511.669,"date":1688169600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":8956.071,"date":1690848000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":8921.834,"date":1693526400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":8187.363,"date":1696118400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":7981.962,"date":1698796800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":7613.625,"date":1701388800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":6963.85,"date":1704067200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":6847.325,"date":1706745600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":6133.363,"date":1709251200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":6079,"date":1711929600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":6549,"date":1714521600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":6779,"date":1715904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":6768,"date":1717718400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Takeda Pharmaceutical Company
                    GlaxoSmithKline
                    Sanofi
                    Pfizer
                    Eisai Co

                    Best Analysts Covering 4523

                    1 Year
                    Unknown AnalystBernstein
                    Not Ranked
                    1 Year Success Rate
                    0/0 ratings generated profit
                    0%
                    1 Year Average Return
                    0.00%
                    reiterated a buy rating 22 days ago
                    Copying Unknown Analyst's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
                    Popular Stocks
                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis